Literature DB >> 33556334

Pathobiology and treatment of viral keratitis.

Raghuram Koganti1, Tejabhiram Yadavalli1, Raza Ali Naqvi2, Deepak Shukla3, Afsar R Naqvi4.   

Abstract

Keratitis is one of the most prevalent ocular diseases manifested by partial or total loss of vision. Amongst infectious (viz., microbes including bacteria, fungi, amebae, and viruses) and non-infectious (viz., eye trauma, chemical exposure, and ultraviolet exposure, contact lens) risk factors, viral keratitis has been demonstrated as one of the leading causes of corneal opacity. While many viruses have been shown to cause keratitis (such as rhabdoviruses, coxsackieviruses, etc.), herpesviruses are the predominant etiologic agent of viral keratitis. This chapter will summarize current knowledge on the prevalence, diagnosis, and pathobiology of viral keratitis. Virus-mediated immunomodulation of host innate and adaptive immune components is critical for viral persistence, and dysfunctional immune responses may cause destruction of ocular tissues leading to keratitis. Immunosuppressed or immunocompromised individuals may display recurring disease with pronounced severity. Early diagnosis of viral keratitis is beneficial for disease management and response to treatment. Finally, we have discussed current and emerging therapies to treat viral keratitis.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral drugs; Host-virus interaction; Human herpesvirus; Inflammation; Ocular infection; Viral keratitis

Mesh:

Substances:

Year:  2021        PMID: 33556334      PMCID: PMC8043992          DOI: 10.1016/j.exer.2021.108483

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  230 in total

Review 1.  Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.

Authors:  N Novak; W M Peng
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis.

Authors:  A Fekkar; B Bodaghi; F Touafek; P Le Hoang; D Mazier; L Paris
Journal:  J Clin Microbiol       Date:  2008-04-09       Impact factor: 5.948

3.  [Microbial keratitis: a 4 year study of risk factors and traditional/complementary medicine in Oman].

Authors:  A Bialasiewicz; R Shenoy; A Thakral; A A Al-Muniri; U Shenoy; Z Al-Mughairi
Journal:  Ophthalmologe       Date:  2006-08       Impact factor: 1.059

4.  Cytomegalovirus infection in pregnancy: should all women be screened?

Authors:  Amanda Carlson; Errol R Norwitz; Robert J Stiller
Journal:  Rev Obstet Gynecol       Date:  2010

Review 5.  Adenoviral keratoconjunctivitis.

Authors:  Vishal Jhanji; Tommy C Y Chan; Emmy Y M Li; Kanika Agarwal; Rasik B Vajpayee
Journal:  Surv Ophthalmol       Date:  2015-05-05       Impact factor: 6.048

6.  Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis.

Authors:  S Fisher; O Genbacev; E Maidji; L Pereira
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Incidence of herpes simplex virus keratitis in France.

Authors:  M Labetoulle; P Auquier; H Conrad; A Crochard; M Daniloski; S Bouée; A El Hasnaoui; J Colin
Journal:  Ophthalmology       Date:  2005-05       Impact factor: 12.079

8.  Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome.

Authors:  K C Chern; D Conrad; G N Holland; D S Holsclaw; L K Schwartz; T P Margolis
Journal:  Arch Ophthalmol       Date:  1998-08

Review 9.  Cytomegalovirus infection in pregnancy.

Authors:  B D Raynor
Journal:  Semin Perinatol       Date:  1993-12       Impact factor: 3.300

10.  Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis.

Authors:  Curtis R Brandt; Radeekorn Akkarawongsa; Sharon Altmann; Gilbert Jose; Aaron W Kolb; Alan J Waring; Robert I Lehrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

View more
  4 in total

1.  Inhibitory effects of luteolin on TLR3-mediated inflammation caused by TAK/NF-κB signaling in human corneal fibroblasts.

Authors:  Zi-Han Guo; Ping-Ping Liu; Heng Wang; Xiu-Xia Yang; Cheng-Cheng Yang; Hui Zheng; Dan Tang; Yang Liu
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

2.  Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.

Authors:  Tejabhiram Yadavalli; Joshua Ames; David Wu; Benjamin Ramirez; Navya Bellamkonda; Deepak Shukla
Journal:  Eur J Pharm Biopharm       Date:  2022-03-21       Impact factor: 5.589

3.  Editorial: Ocular infection of herpes: Immunology, pathogenesis, and interventions.

Authors:  Tejabhiram Yadavalli; Chandrashekhar Patil; Dinesh Jaishankar; Rahul Suryawanshi
Journal:  Front Microbiol       Date:  2022-07-26       Impact factor: 6.064

Review 4.  Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man.

Authors:  Anthony J St Leger; David M Koelle; Paul R Kinchington; Georges Michel G M Verjans
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.